Form 8-K - Current report
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices; zip code)
Registrant’s telephone number, includingarea code:
N/A
(Former name or former address, if changed sincelast report)
Check the appropriate box below if the Form 8-Kfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrantis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of theSecurities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accountingstandards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b)of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The |
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
On September 19, 2023, Applied DNA Sciences, Inc. (the “Company”)held its 2023 annual meeting of stockholders (the “2023 Annual Meeting”). The following proposals were voted on and were approvedby the Company’s stockholders, except with respect to proposal 2 which was not approved, at the 2023 Annual Meeting with the stockholdershaving voted as set forth below:
I. To elect six directors to serve until the 2024 annual meeting ofstockholders or until their respective successors are duly elected and qualified.
| FOR | WITHHELD | BROKER NON- VOTES | ||||||||||
| James A. Hayward | 3,591,642 | 383,602 | 3,105,530 | |||||||||
| Robert B. Catell | 3,572,859 | 402,385 | 3,105,530 | |||||||||
| Joseph D. Ceccoli | 3,154,216 | 821,028 | 3,105,530 | |||||||||
| Yacov A. Shamash | 3,005,706 | 969,538 | 3,105,530 | |||||||||
| Sanford R. Simon | 3,514,258 | 460,986 | 3,105,530 | |||||||||
| Elizabeth Schmalz Shaheen | 3,089,726 | 885,518 | 3,105,530 | |||||||||
II. To approve an amendment to the Company’s 2020 Equity IncentivePlan, to increase the number of shares of common stock authorized for issuance by an additional 3,500,000.
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTES | |||
| 2,520,302 | 1,368,359 | 86,583 | 3,105,530 |
III. To ratify the appointment of Marcum LLP as the Company’sindependent registered public accounting firm for the fiscal year ending September30, 2023.
| FOR | AGAINST | ABSTAIN | ||
| 6,504,292 | 476,312 | 100,170 |
Each of the foregoing voting results from the 2023 Annual Meeting isfinal.
SIGNATURE
Pursuant to the requirementsof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereuntoduly authorized.
| Date: September 20, 2023 | APPLIED DNA SCIENCES, INC. | |
| By: | /s/ James A. Hayward | |
| Name: | James A. Hayward | |
Cover | Sep. 19, 2023 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Sep. 19, 2023 |
| Entity File Number | 001-36745 |
| Entity Registrant Name | Applied DNA Sciences, Inc. |
| Entity Central Index Key | 0000744452 |
| Entity Tax Identification Number | 59-2262718 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 50 Health Sciences Drive |
| Entity Address, City or Town | Stony Brook |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 11790 |
| City Area Code | 631 |
| Local Phone Number | 240-8800 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value |
| Trading Symbol | APDN |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2024 to Jun 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Jun 2023 to Jun 2024
 | {{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}} |
Loading Messages....
Applied DNA Sciences Inc News
Loading Messages....
`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `
`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `
FEATURED
•{{ article.source }} • {{ article.date}} {{article.time}}
`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Form PRE 14A - Other preliminary proxy statements","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/94016451\/form-pre-14a-other-preliminary-proxy-statements","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1718052934,"date":"Mon Jun 10, 2024 ","time":"4:55 PM (3 weeks ago)","full_date":"June 10, 2024 4:55 PM","post_time":"June 10 2024","article_id":94016451,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/94008211\/form-sc-13g-statement-of-acquisition-of-benefici","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717793045,"date":"Fri Jun 07, 2024 ","time":"4:44 PM (3 weeks ago)","full_date":"June 7, 2024 4:44 PM","post_time":"June 07 2024","article_id":94008211,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/94007362\/form-sc-13g-statement-of-acquisition-of-benefici","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717790480,"date":"Fri Jun 07, 2024 ","time":"4:01 PM (3 weeks ago)","full_date":"June 7, 2024 4:01 PM","post_time":"June 07 2024","article_id":94007362,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SC 13G\/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93972273\/form-sc-13g-a-statement-of-acquisition-of-benefi","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717431838,"date":"Mon Jun 03, 2024 ","time":"12:23 PM (4 weeks ago)","full_date":"June 3, 2024 12:23 PM","post_time":"June 03 2024","article_id":93972273,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93945826\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717014824,"date":"Wed May 29, 2024 ","time":"4:33 PM (4 weeks ago)","full_date":"May 29, 2024 4:33 PM","post_time":"May 29 2024","article_id":93945826,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form EFFECT - Notice of Effectiveness","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93940622\/form-effect-notice-of-effectiveness","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716956104,"date":"Wed May 29, 2024 ","time":"12:15 AM (1 month ago)","full_date":"May 29, 2024 12:15 AM","post_time":"May 29 2024","article_id":93940622,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 424B4 - Prospectus [Rule 424(b)(4)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93940617\/form-424b4-prospectus-rule-424b4","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716947056,"date":"Tue May 28, 2024 ","time":"9:44 PM (1 month ago)","full_date":"May 28, 2024 9:44 PM","post_time":"May 28 2024","article_id":93940617,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93925354\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716581545,"date":"Fri May 24, 2024 ","time":"4:12 PM (1 month ago)","full_date":"May 24, 2024 4:12 PM","post_time":"May 24 2024","article_id":93925354,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93909278\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716409613,"date":"Wed May 22, 2024 ","time":"4:26 PM (1 month ago)","full_date":"May 22, 2024 4:26 PM","post_time":"May 22 2024","article_id":93909278,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93899678\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716311132,"date":"Tue May 21, 2024 ","time":"1:05 PM (1 month ago)","full_date":"May 21, 2024 1:05 PM","post_time":"May 21 2024","article_id":93899678,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93873675\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715894733,"date":"Thu May 16, 2024 ","time":"5:25 PM (1 month ago)","full_date":"May 16, 2024 5:25 PM","post_time":"May 16 2024","article_id":93873675,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93854923\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715737838,"date":"Tue May 14, 2024 ","time":"9:50 PM (1 month ago)","full_date":"May 14, 2024 9:50 PM","post_time":"May 14 2024","article_id":93854923,"source_id":"edgar2","media_url":null,"press_release":true}],"All News": [{"headline":"Form PRE 14A - Other preliminary proxy statements","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/94016451\/form-pre-14a-other-preliminary-proxy-statements","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1718052934,"date":"Mon Jun 10, 2024 ","time":"4:55 PM (3 weeks ago)","full_date":"June 10, 2024 4:55 PM","post_time":"June 10 2024","article_id":94016451,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/94008211\/form-sc-13g-statement-of-acquisition-of-benefici","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717793045,"date":"Fri Jun 07, 2024 ","time":"4:44 PM (3 weeks ago)","full_date":"June 7, 2024 4:44 PM","post_time":"June 07 2024","article_id":94008211,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/94007362\/form-sc-13g-statement-of-acquisition-of-benefici","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717790480,"date":"Fri Jun 07, 2024 ","time":"4:01 PM (3 weeks ago)","full_date":"June 7, 2024 4:01 PM","post_time":"June 07 2024","article_id":94007362,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SC 13G\/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93972273\/form-sc-13g-a-statement-of-acquisition-of-benefi","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717431838,"date":"Mon Jun 03, 2024 ","time":"12:23 PM (4 weeks ago)","full_date":"June 3, 2024 12:23 PM","post_time":"June 03 2024","article_id":93972273,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93945826\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717014824,"date":"Wed May 29, 2024 ","time":"4:33 PM (4 weeks ago)","full_date":"May 29, 2024 4:33 PM","post_time":"May 29 2024","article_id":93945826,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form EFFECT - Notice of Effectiveness","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93940622\/form-effect-notice-of-effectiveness","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716956104,"date":"Wed May 29, 2024 ","time":"12:15 AM (1 month ago)","full_date":"May 29, 2024 12:15 AM","post_time":"May 29 2024","article_id":93940622,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 424B4 - Prospectus [Rule 424(b)(4)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93940617\/form-424b4-prospectus-rule-424b4","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716947056,"date":"Tue May 28, 2024 ","time":"9:44 PM (1 month ago)","full_date":"May 28, 2024 9:44 PM","post_time":"May 28 2024","article_id":93940617,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93925354\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716581545,"date":"Fri May 24, 2024 ","time":"4:12 PM (1 month ago)","full_date":"May 24, 2024 4:12 PM","post_time":"May 24 2024","article_id":93925354,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93909278\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716409613,"date":"Wed May 22, 2024 ","time":"4:26 PM (1 month ago)","full_date":"May 22, 2024 4:26 PM","post_time":"May 22 2024","article_id":93909278,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93899678\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1716311132,"date":"Tue May 21, 2024 ","time":"1:05 PM (1 month ago)","full_date":"May 21, 2024 1:05 PM","post_time":"May 21 2024","article_id":93899678,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93873675\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715894733,"date":"Thu May 16, 2024 ","time":"5:25 PM (1 month ago)","full_date":"May 16, 2024 5:25 PM","post_time":"May 16 2024","article_id":93873675,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form S-1\/A - General form for registration of securities under the Securities Act of 1933: [Amend]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/applied-dna-sciences-APDN\/stock-news\/93854923\/form-s-1-a-general-form-for-registration-of-secu","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715737838,"date":"Tue May 14, 2024 ","time":"9:50 PM (1 month ago)","full_date":"May 14, 2024 9:50 PM","post_time":"May 14 2024","article_id":93854923,"source_id":"edgar2","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});
More Applied DNA Sciences Inc News Articles
